tradingkey.logo
tradingkey.logo
Pesquisar

Integra Lifesciences Holdings Corp

IART
Adicionar à lista de desejos
18.050USD
+0.160+0.89%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
1.41BValor de mercado
PerdaP/L TTM

Mais detalhes de Integra Lifesciences Holdings Corp Empresa

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Informações de Integra Lifesciences Holdings Corp

Código da empresaIART
Nome da EmpresaIntegra Lifesciences Holdings Corp
Data de listagemAug 16, 1995
CEOPoul (Mojdeh)
Número de funcionários4396
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 16
Endereço1100 Campus Road
CidadePRINCETON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08540
Telefone16092750500
Sitehttps://www.integralife.com/
Código da empresaIART
Data de listagemAug 16, 1995
CEOPoul (Mojdeh)

Executivos da empresa Integra Lifesciences Holdings Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

Perguntas frequentes

Quem são os cinco principais acionistas de Integra Lifesciences Holdings Corp?

Os cinco principais acionistas de Integra Lifesciences Holdings Corp são: Ms. Mojdeh Poul

Quantas instituições possuem ações da Integra Lifesciences Holdings Corp (IART)?

Em 2026Q1, 574 instituições possuíam ações da Integra Lifesciences Holdings Corp, com valor de mercado aproximado de 82.80M, representando 106.43% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -14508057.00.

Qual é a maior fonte de receita da Integra Lifesciences Holdings Corp?

Em 2026Q1, o segmento de negócios Neurosurgery gerou a maior receita para Integra Lifesciences Holdings Corp, totalizando 827.67M e representando 50.61% da receita total.